Search
for
Sort by
Research 30 of 287
- Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- 176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Holistic Ayurvedic Management of Psoriasis with special reference to Eka Kustha
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- EFFECTIVENESS OF BAKUCHI (PSORALEA CORYLIFOLIA LINN.) AS RASAYANA THERAPY IN PSORIASIS - A CASE REPORT
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double‐blinded clinical trial
- Dovobet ointment under occlusion overnight for troublesome scalp psoriasis
- Dermpath & Clinic: Telangiectasia macularis eruptiva perstans
- 128 Bimekizumab led to rapid & deep normalisation of molecular signatures associated with PASI sub-components, preceding clinical skin clearance
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- Impact of ustekinumab on quality of life and sexual difficulties associated with psoriasis: Results from phase III clinical trials
- Fluticasone Propionate-loaded Black Cumin Oil NLCs with Dual Deposition/Permeation Capabilities for Enhanced Psoriasis Management
- MANAGEMENT OF EKAKUSTHA (PLAQUE PSORIASIS) THROUGH INTEGRATED SHODHANA AND SHAMANA CHIKITSA: A SINGLE CASE STUDY
- MANAGEMENT OF EKAKUSTHA (PLAQUE PSORIASIS) THROUGH INTEGRATED SHODHANA AND SHAMANA CHIKITSA: A SINGLE CASE STUDY
- New Topical Treatment for Psoriasis
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab
- Niosomes as a propitious carrier for topical drug delivery
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Guidelines for the Use of Acitretin in Psoriasis
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Standardized classification tools in dermatology: time to focus on cutaneous warts
- Interventions for nail psoriasis
- Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings